Continuous Glucose Monitoring to Aid Weight Loss in Prediabetes

Trial ID or NCT#

NCT03844646

Status

not recruiting iconNOT RECRUITING

Purpose

The primary objective of this study is to determine whether intermittent use of continuous glucose monitor will facilitate weight loss in individuals who are overweight/obese with prediabetes.

Official Title

Real-Time Continuous Glucose Monitoring to Aid Weight Loss in Prediabetes

Eligibility Criteria

Ages Eligible for Study: 18 Years to 99 Years
Sexes Eligible for Study: All
Accepts Healthy Volunteers: Yes
Inclusion Criteria:
  1. - Overweight/obese (BMI 25-40 kg/m2) - Prediabetes (fasting glucose 100-125 mg/dL and/or HbA1c 5.7-6.4%)
Exclusion Criteria:
  1. - On glucose-lowering medications (e.g., metformin) - On weight-loss medications

Investigator(s)

Sun Kim, M.D. M.S.
Sun Kim, M.D. M.S.
Endocrinologist
Associate Professor of Medicine (Endocrinology)

Contact us to find out if this trial is right for you.

Contact

Associate Professor
650-723-8284